Dadun Dadun cabecera universidad cabecera biblioteca
   (New user)
Help  | Contact  |  Castellano English  
 

Dadun > Depósito Académico > CIMA (Centro de Investigación Médica Aplicada) > Área de Terapia génica y Hepatología > Inmunología hepatitis virales > DA - CIMA - Terapia génica y Hepatología - Inmunología hepatitis virales - Artículos de revista >

Synthesis and evaluation of new Reissert analogs as HIV-1 RT inhibitors. 2. Benzo[f]quinoline and pyridine derivatives
Authors: Monge, A. (Antonio)
Alvarez, E. (E)
Sanmartin-Grijalba, C. (Carmen)
Nadal, E. (Ernest)
Ruiz, I. (I)
Font, M. (María)
Martinez-Irujo, J.J. (Juan José)
Santiago, E. (Esteban)
Prieto, I. (Inés)
Lasarte, J.J. (Juan José)
Sarobe, P. (Pablo)
Borras-Cuesta, F. (Francisco)
Keywords: Anti-HIV Agents/chemical synthesis
HIV Reverse Transcriptase/antagonists & inhibitors
Pyridines/chemical synthesis
Quinolines/chemical synthesis*
Reverse Transcriptase Inhibitors/chemical synthesis
Issue Date: 1997
Publisher: Informa Healthcare
ISSN: 1029-2322
Citation: Monge A, Alvarez E, San Martin C, Nadal E, Ruiz I, Font M, et al. Synthesis and evaluation of new Reissert analogs as HIV-1 RT inhibitors. 2. Benzo[f]quinoline and pyridine derivatives. Drug Des Discov 1997 Apr;14(4):291-303.
Abstract
The synthesis and preliminary evaluation of new benzo[f]quinoline and pyridine derivatives, obtained by application of the Reissert method and its modifications, as HIV-1 RT inhibitors and anti-infectives are presented. The most active products against HIV-1 RT wild type are the ethyl 2-cyano-1,2-dihydrobenzo[f]quinoline-1-carboxylate 2b, propyl 2-cyano-1,2-dihydrobenzo[f]quinoline-1-carboxylate 2c, and 2-cyano-1-(2'-furoyl)-1,2-dihydrobenzo[f]quinoline 2n, which maintain their activity against the mutant type P236L, resulting inactive against the Y181C type. Using the data previously obtained by our research team for analogous series derived from quinoline as reference, the compounds which have now been obtained present an increase in the cytotoxic character attributable to the introduction of a benzene ring fused with the quinoline base nucleus, as well as a decrease of the activity as HIV-1 RT inhibitors when the quinoline benzenic ring is eliminated.
Permanent link: http://hdl.handle.net/10171/21725
Appears in Collections:DA - CIMA - Terapia génica y Hepatología - Inmunología experimental - Artículos de revista
DA - Medicina - Medicina Interna - Artículos de revista
DA - CIMA - Terapia génica y Hepatología - Inmunología hepatitis virales - Artículos de revista

Files in This Item:

There are no files associated with this item.

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.